Sarepta Therapeutics (SRPT) Treasury Shares (2010 - 2026)

Sarepta Therapeutics' Treasury Shares history runs 16 years deep, the most recent figure standing at $655642.0 for Q1 2026.

• On a quarterly basis, Treasury Shares changed N/A year-over-year to $655642.0 in Q1 2026; TTM through Mar 2026 was $655642.0, a N/A change from a year earlier, with the FY2025 full-year figure at $650876.0, up 15.46% from the prior year.
• Treasury Shares held at $25.3 million in Q1 2026 per SRPT's latest filing, from $25.3 million in the prior quarter.
• Across five years, Treasury Shares topped out at $2.2 million in Q4 2023 and bottomed at -$651000.0 in Q2 2025.
• The 4-year median for Treasury Shares is $653259.0 (2025), against an average of $896088.3.
• Across the five-year window, Treasury Shares surged 38.59% in 2022 and rose 22.46% in 2023, its largest moves.
• Year by year, Treasury Shares stood at $25.3 million in 2025, then changed by 0.0% to $25.3 million in 2026.
• Per Business Quant, the three latest SRPT Treasury Shares figures stand at $25.3 million (Q1 2026), $25.3 million (Q4 2025), and $25.3 million (Q3 2025).